In late July 2025, a rumor spread widely across social media platforms that billionaire investor Bill Gates received approval ...

Natural products have been an inspiration for the development of new pharmaceuticals with nearly half of all present small-molecule drugs designed or derived based on some natural compound.

US RNA interference (RNAi)specialist Arrowhead Pharmaceuticals (Nasdaq: ARWR) today announced that its majority-owned subsidiary Visirna Therapeutics has signed an asset purchase agreement with France ...

The global pharmaceutical lipids market is set for significant expansion, with a new forecast projecting a value of USD9.0 billion by 2035, growing from USD5.4 billion in 2025 at a compound annual ...

ProQR Announces Upcoming Presentation at RNA Editing SummitLEIDEN, Netherlands & CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated ...

--GreenLight Biosciences Holdings PBC today announced a licensing agreement with Serum Institute of India, Pvt, Ltd., aimed at accelerating accessibility to messenger RNA products in emerging ...

QuantumScale Single Cell RNA kits are already powering the analysis of millions of cells from Scale Bio’s “100 Million Cell Challenge,” a global initiative aimed at pushing the boundaries of ...

Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agen ...

Viome Life Sciences Secures $86.5M for At-home Tests and Health Products Viome Life Sciences' Series C funding round included participation from Khosla Ventures, Bold Capital and WRG Ventures.

Scale Biosciences Launches Five Single Cell Profiling Products, Unlocking Single Cell RNA Studies at Any Scale The QuantumScale platform enables costs of less than 1 cent per cell with workflows ...